Trial compares responses to BTX-A, BTX-B

Article

New Orleans - Results of a preliminary, double-blind, parallel group study demonstrate the efficacy of botulinum toxin type A (BTX-A, Botox) 20 units and botulinum toxin type B (BTX-B, Myobloc) 1,000 and 2,000 units for correcting deep glabellar furrows.

Related Videos
Related Content

Holistic Aesthetics Center to Host First Annual Symposium in Middletown, New York

September 24th 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

Pointers With Portela: What to Know About Ozempic

September 19th 2023

The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice

March 17th 2022

Insights Into Aesthetic Next With Katie Martin, PA-C

September 15th 2023

Understanding the Role of Amino Acids and Proteins in Skin Care

September 14th 2023

Holistic Aesthetics Center to Host First Annual Symposium in Middletown, New York

September 24th 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

Pointers With Portela: What to Know About Ozempic

September 19th 2023

The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice

March 17th 2022

Insights Into Aesthetic Next With Katie Martin, PA-C

September 15th 2023

Understanding the Role of Amino Acids and Proteins in Skin Care

September 14th 2023

Holistic Aesthetics Center to Host First Annual Symposium in Middletown, New York

September 24th 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

Pointers With Portela: What to Know About Ozempic

September 19th 2023

The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice

March 17th 2022

Insights Into Aesthetic Next With Katie Martin, PA-C

September 15th 2023

Understanding the Role of Amino Acids and Proteins in Skin Care

September 14th 2023
© 2023 MJH Life Sciences

All rights reserved.